| |
| |
|
| Insider
Information: |
Namouni Fouad |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
77,313 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,640,692 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
77,313 |
|
|
| Total
Value |
$6,640,692 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Blueprint Medicines Corp |
BPMC |
|
2024-03-07 |
72,703 |
2020-10-01 |
0 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2021-06-30 |
4,610 |
2021-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BPMC |
Blueprint Medicines Corp |
PRESIDENT, R & D |
• – – |
2024-03-07 |
4 |
S |
$90.69 |
$396,950 |
D/D |
(4,377) |
72,703 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
PRESIDENT, R & D |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
77,080 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
PRESIDENT, R & D |
• – – |
2023-10-04 |
4 |
S |
$48.06 |
$181,138 |
D/D |
(3,769) |
62,080 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
PRESIDENT, R & D |
• – – |
2023-03-06 |
4 |
S |
$44.36 |
$88,977 |
D/D |
(1,948) |
65,849 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
PRESIDENT, R & D |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
67,797 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
PRESIDENT, R & D |
• – – |
2022-10-04 |
4 |
S |
$67.30 |
$234,002 |
D/D |
(3,477) |
52,797 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
PRESIDENT, R & D |
• – – |
2022-03-07 |
4 |
S |
$56.19 |
$58,831 |
D/D |
(1,047) |
56,274 |
0 |
% |
|
| BPMC |
Blueprint Medicines Corp |
PRESIDENT, R & D |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
57,321 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
President, R & D |
• – – |
2021-10-05 |
4 |
S |
$98.18 |
$318,201 |
D/D |
(3,241) |
42,321 |
0 |
% |
|
| APRE |
Aprea Therapeutics, Inc. |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,610 |
4,610 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
President, R & D |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,062 |
45,562 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
President, R & D |
• – – |
2020-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
32,500 |
32,500 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
